Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Capital Leases (2015 - 2016)

Grifols' (GIFLF) quarterly Capital Leases came in at $6.9 million in Q1 2016, up 7.56% quarter-over-quarter from $6.4 million in Q4 2015.

Analysis

Grifols (GIFLF) Capital Leases (2015 - 2016) Analysis & Trends

Grifols (GIFLF) has reported Capital Leases for 2 consecutive years, with $6.9 million the latest figure, recorded in Q1 2016.

  • For the quarter ending Q1 2016, Capital Leases changed N/A year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2016 stood at $6.9 million (changed N/A YoY), and the FY2015 full-year result was $6.4 million, changed N/A from the prior year.
  • Capital Leases grew to $6.9 million in Q1 2016 per GIFLF's latest filing, from $6.4 million in the prior quarter.
  • Across five years, Capital Leases topped out at $6.9 million in Q1 2016 and bottomed at $6.4 million in Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 6.90 Mn
Dec 31, 2015 6.41 Mn